 | • レポートコード：GIR-107A12439 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、肺がん診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。肺がん診断の種類別市場規模（イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他）、用途別市場規模（工業、医療、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・肺がん診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche Diagnostics、BioMérieux、Qiagen、Advpharma、AIT Austrian Institute of Technology、Courtagen Life Sciences、DiagnoCure、BioMark Diagnostics、Mayo Clinic、HalioDx SAS ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他 ・用途別分析2016年-2026年：工業、医療、その他 ・肺がん診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・肺がん診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・肺がん診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・肺がん診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・肺がん診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Lung Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Lung Cancer Diagnostics size is estimated to be USD 2394.1 million in 2026 from USD 1938 million in 2020, with a change XX% between 2020 and 2021. The global Lung Cancer Diagnostics market size is expected to grow at a CAGR of 5.4% for the next five years.
Market segmentation
Lung Cancer Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other
Market segment by Application, can be divided into
Industrial
Healthcare
Other
Market segment by players, this report covers
Roche Diagnostics
BioMérieux
Qiagen
Advpharma
AIT Austrian Institute of Technology
Courtagen Life Sciences
DiagnoCure
BioMark Diagnostics
Mayo Clinic
HalioDx SAS
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Lung Cancer Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Lung Cancer Diagnostics, with revenue, gross margin and global market share of Lung Cancer Diagnostics from 2019 to 2021.
Chapter 3, the Lung Cancer Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Lung Cancer Diagnostics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Lung Cancer Diagnostics research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Lung Cancer Diagnostics
1.2 Classification of Lung Cancer Diagnostics by Type
1.2.1 Overview: Global Lung Cancer Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Lung Cancer Diagnostics Revenue Market Share by Type in 2020
1.2.3 Immunoassays
1.2.4 Flow Cytometry
1.2.5 Rapid Tests
1.2.6 Molecular Assays
1.2.7 Tissue Arrays
1.2.8 Circulating Tumor Cells
1.2.9 Pharmacodiagnostics
1.2.10 Biomarkers
1.2.11 Other
1.3 Global Lung Cancer Diagnostics Market by Application
1.3.1 Overview: Global Lung Cancer Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Industrial
1.3.3 Healthcare
1.3.4 Other
1.4 Global Lung Cancer Diagnostics Market Size & Forecast
1.5 Global Lung Cancer Diagnostics Market Size and Forecast by Region
1.5.1 Global Lung Cancer Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Lung Cancer Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America Lung Cancer Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe Lung Cancer Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Lung Cancer Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America Lung Cancer Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Lung Cancer Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Lung Cancer Diagnostics Market Drivers
1.6.2 Lung Cancer Diagnostics Market Restraints
1.6.3 Lung Cancer Diagnostics Trends Analysis
2 Company Profiles
2.1 Roche Diagnostics
2.1.1 Roche Diagnostics Details
2.1.2 Roche Diagnostics Major Business
2.1.3 Roche Diagnostics Lung Cancer Diagnostics Product and Solutions
2.1.4 Roche Diagnostics Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Roche Diagnostics Recent Developments and Future Plans
2.2 BioMérieux
2.2.1 BioMérieux Details
2.2.2 BioMérieux Major Business
2.2.3 BioMérieux Lung Cancer Diagnostics Product and Solutions
2.2.4 BioMérieux Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 BioMérieux Recent Developments and Future Plans
2.3 Qiagen
2.3.1 Qiagen Details
2.3.2 Qiagen Major Business
2.3.3 Qiagen Lung Cancer Diagnostics Product and Solutions
2.3.4 Qiagen Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Qiagen Recent Developments and Future Plans
2.4 Advpharma
2.4.1 Advpharma Details
2.4.2 Advpharma Major Business
2.4.3 Advpharma Lung Cancer Diagnostics Product and Solutions
2.4.4 Advpharma Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Advpharma Recent Developments and Future Plans
2.5 AIT Austrian Institute of Technology
2.5.1 AIT Austrian Institute of Technology Details
2.5.2 AIT Austrian Institute of Technology Major Business
2.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Product and Solutions
2.5.4 AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 AIT Austrian Institute of Technology Recent Developments and Future Plans
2.6 Courtagen Life Sciences
2.6.1 Courtagen Life Sciences Details
2.6.2 Courtagen Life Sciences Major Business
2.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Product and Solutions
2.6.4 Courtagen Life Sciences Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Courtagen Life Sciences Recent Developments and Future Plans
2.7 DiagnoCure
2.7.1 DiagnoCure Details
2.7.2 DiagnoCure Major Business
2.7.3 DiagnoCure Lung Cancer Diagnostics Product and Solutions
2.7.4 DiagnoCure Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 DiagnoCure Recent Developments and Future Plans
2.8 BioMark Diagnostics
2.8.1 BioMark Diagnostics Details
2.8.2 BioMark Diagnostics Major Business
2.8.3 BioMark Diagnostics Lung Cancer Diagnostics Product and Solutions
2.8.4 BioMark Diagnostics Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 BioMark Diagnostics Recent Developments and Future Plans
2.9 Mayo Clinic
2.9.1 Mayo Clinic Details
2.9.2 Mayo Clinic Major Business
2.9.3 Mayo Clinic Lung Cancer Diagnostics Product and Solutions
2.9.4 Mayo Clinic Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Mayo Clinic Recent Developments and Future Plans
2.10 HalioDx SAS
2.10.1 HalioDx SAS Details
2.10.2 HalioDx SAS Major Business
2.10.3 HalioDx SAS Lung Cancer Diagnostics Product and Solutions
2.10.4 HalioDx SAS Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 HalioDx SAS Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Lung Cancer Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Lung Cancer Diagnostics Players Market Share
3.2.2 Top 10 Lung Cancer Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 Lung Cancer Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Lung Cancer Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global Lung Cancer Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Lung Cancer Diagnostics Revenue Market Share by Application (2016-2021)
5.2 Lung Cancer Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Lung Cancer Diagnostics Revenue by Type (2016-2026)
6.2 North America Lung Cancer Diagnostics Revenue by Application (2016-2026)
6.3 North America Lung Cancer Diagnostics Market Size by Country
6.3.1 North America Lung Cancer Diagnostics Revenue by Country (2016-2026)
6.3.2 United States Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Lung Cancer Diagnostics Revenue by Type (2016-2026)
7.2 Europe Lung Cancer Diagnostics Revenue by Application (2016-2026)
7.3 Europe Lung Cancer Diagnostics Market Size by Country
7.3.1 Europe Lung Cancer Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Lung Cancer Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific Lung Cancer Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific Lung Cancer Diagnostics Market Size by Region
8.3.1 Asia-Pacific Lung Cancer Diagnostics Revenue by Region (2016-2026)
8.3.2 China Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Lung Cancer Diagnostics Revenue by Type (2016-2026)
9.2 South America Lung Cancer Diagnostics Revenue by Application (2016-2026)
9.3 South America Lung Cancer Diagnostics Market Size by Country
9.3.1 South America Lung Cancer Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Lung Cancer Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa Lung Cancer Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa Lung Cancer Diagnostics Market Size by Country
10.3.1 Middle East & Africa Lung Cancer Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE Lung Cancer Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Lung Cancer Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Lung Cancer Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Lung Cancer Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Lung Cancer Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Lung Cancer Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. Roche Diagnostics Corporate Information, Head Office, and Major Competitors
Table 7. Roche Diagnostics Major Business
Table 8. Roche Diagnostics Lung Cancer Diagnostics Product and Solutions
Table 9. Roche Diagnostics Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. BioMérieux Corporate Information, Head Office, and Major Competitors
Table 11. BioMérieux Major Business
Table 12. BioMérieux Lung Cancer Diagnostics Product and Solutions
Table 13. BioMérieux Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Qiagen Corporate Information, Head Office, and Major Competitors
Table 15. Qiagen Major Business
Table 16. Qiagen Lung Cancer Diagnostics Product and Solutions
Table 17. Qiagen Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Advpharma Corporate Information, Head Office, and Major Competitors
Table 19. Advpharma Major Business
Table 20. Advpharma Lung Cancer Diagnostics Product and Solutions
Table 21. Advpharma Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. AIT Austrian Institute of Technology Corporate Information, Head Office, and Major Competitors
Table 23. AIT Austrian Institute of Technology Major Business
Table 24. AIT Austrian Institute of Technology Lung Cancer Diagnostics Product and Solutions
Table 25. AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Courtagen Life Sciences Corporate Information, Head Office, and Major Competitors
Table 27. Courtagen Life Sciences Major Business
Table 28. Courtagen Life Sciences Lung Cancer Diagnostics Product and Solutions
Table 29. Courtagen Life Sciences Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. DiagnoCure Corporate Information, Head Office, and Major Competitors
Table 31. DiagnoCure Major Business
Table 32. DiagnoCure Lung Cancer Diagnostics Product and Solutions
Table 33. DiagnoCure Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. BioMark Diagnostics Corporate Information, Head Office, and Major Competitors
Table 35. BioMark Diagnostics Major Business
Table 36. BioMark Diagnostics Lung Cancer Diagnostics Product and Solutions
Table 37. BioMark Diagnostics Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Mayo Clinic Corporate Information, Head Office, and Major Competitors
Table 39. Mayo Clinic Major Business
Table 40. Mayo Clinic Lung Cancer Diagnostics Product and Solutions
Table 41. Mayo Clinic Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. HalioDx SAS Corporate Information, Head Office, and Major Competitors
Table 43. HalioDx SAS Major Business
Table 44. HalioDx SAS Lung Cancer Diagnostics Product and Solutions
Table 45. HalioDx SAS Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Lung Cancer Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 47. Global Lung Cancer Diagnostics Revenue Share by Players (2019-2021)
Table 48. Breakdown of Lung Cancer Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Lung Cancer Diagnostics Players Head Office, Products and Services Provided
Table 50. Lung Cancer Diagnostics Mergers & Acquisitions in the Past Five Years
Table 51. Lung Cancer Diagnostics New Entrants and Expansion Plans
Table 52. Global Lung Cancer Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 53. Global Lung Cancer Diagnostics Revenue Share by Type (2016-2021)
Table 54. Global Lung Cancer Diagnostics Revenue Forecast by Type (2021-2026)
Table 55. Global Lung Cancer Diagnostics Revenue by Application (2016-2021)
Table 56. Global Lung Cancer Diagnostics Revenue Forecast by Application (2021-2026)
Table 57. North America Lung Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Lung Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Lung Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Lung Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Lung Cancer Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Lung Cancer Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Lung Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Lung Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Lung Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Lung Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Lung Cancer Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Lung Cancer Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Lung Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Lung Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Lung Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Lung Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Lung Cancer Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Lung Cancer Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Lung Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Lung Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Lung Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Lung Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Lung Cancer Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Lung Cancer Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Lung Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Lung Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Lung Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Lung Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Lung Cancer Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Lung Cancer Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Lung Cancer Diagnostics Picture
Figure 2. Global Lung Cancer Diagnostics Revenue Market Share by Type in 2020
Figure 3. Immunoassays
Figure 4. Flow Cytometry
Figure 5. Rapid Tests
Figure 6. Molecular Assays
Figure 7. Tissue Arrays
Figure 8. Circulating Tumor Cells
Figure 9. Pharmacodiagnostics
Figure 10. Biomarkers
Figure 11. Other
Figure 12. Lung Cancer Diagnostics Revenue Market Share by Application in 2020
Figure 13. Industrial Picture
Figure 14. Healthcare Picture
Figure 15. Other Picture
Figure 16. Global Lung Cancer Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 17. Global Lung Cancer Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 18. Global Lung Cancer Diagnostics Revenue Market Share by Region (2016-2026)
Figure 19. Global Lung Cancer Diagnostics Revenue Market Share by Region in 2020
Figure 20. North America Lung Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Europe Lung Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Asia-Pacific Lung Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. South America Lung Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Middle East and Africa Lung Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. Lung Cancer Diagnostics Market Drivers
Figure 26. Lung Cancer Diagnostics Market Restraints
Figure 27. Lung Cancer Diagnostics Market Trends
Figure 28. Roche Diagnostics Recent Developments and Future Plans
Figure 29. BioMérieux Recent Developments and Future Plans
Figure 30. Qiagen Recent Developments and Future Plans
Figure 31. Advpharma Recent Developments and Future Plans
Figure 32. AIT Austrian Institute of Technology Recent Developments and Future Plans
Figure 33. Courtagen Life Sciences Recent Developments and Future Plans
Figure 34. DiagnoCure Recent Developments and Future Plans
Figure 35. BioMark Diagnostics Recent Developments and Future Plans
Figure 36. Mayo Clinic Recent Developments and Future Plans
Figure 37. HalioDx SAS Recent Developments and Future Plans
Figure 38. Global Lung Cancer Diagnostics Revenue Share by Players in 2020
Figure 39. Lung Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players Lung Cancer Diagnostics Revenue Market Share in 2020
Figure 41. Global Top 10 Players Lung Cancer Diagnostics Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global Lung Cancer Diagnostics Revenue Share by Type in 2020
Figure 44. Global Lung Cancer Diagnostics Market Share Forecast by Type (2021-2026)
Figure 45. Global Lung Cancer Diagnostics Revenue Share by Application in 2020
Figure 46. Global Lung Cancer Diagnostics Market Share Forecast by Application (2021-2026)
Figure 47. North America Lung Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 48. North America Lung Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 49. North America Lung Cancer Diagnostics Revenue Market Share by Country (2016-2026)
Figure 50. United States Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe Lung Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 54. Europe Lung Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 55. Europe Lung Cancer Diagnostics Revenue Market Share by Country (2016-2026)
Figure 56. Germany Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific Lung Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific Lung Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Lung Cancer Diagnostics Revenue Market Share by Region (2016-2026)
Figure 64. China Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Lung Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 71. South America Lung Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 72. South America Lung Cancer Diagnostics Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa Lung Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa Lung Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa Lung Cancer Diagnostics Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE Lung Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界の新がん診断市場予測（～2024年） Cancer diagnosis frequently requires imaging studies that in many cases use small amounts of radiation. Scope of the Report: The global Emerging Cancer Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between …- 世界の肺がん治療薬市場 2021：企業別、地域別、種類・用途別 The Lung Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 肺がん手術市場：世界及び中国市場分析・予測（～2024年） Lung Cancer Surgery Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Lung Cancer Surgery industry with a focus on the Chinese market. The report provides key statistics on the market status of the Lung Cancer Surgery manufactur…
- 世界の分子診断がん市場 2021：企業別、地域別、種類・用途別 The Molecular Diagnostics Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 非小細胞肺がん治療薬の世界市場 2019年版：種類別（生物製剤、小分子標的療法、化学療法、その他）、用途別（肺腺がん、扁平上皮肺がん、大細胞肺がん） Scope of the Report: The global Non-small Cell Lung Cancer Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in…